$0.17 0.00 (-2.66%)
2/13/2012 11:36 AM

Telik, Inc. (NASDAQ:TELK)

CAPS Rating: 1 out of 5

A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.

Results 1 - 17 of 17

Recs

4
Member Avatar YeahBuddy79 (96.55) Submitted: 5/5/2008 10:56:39 PM : Underperform Start Price: $2.16 TELK Score: +92.07

Embarrassing at best. All the posts have already noted the deaths and that it kills people. As if that is not enough for you, this stock has a bad track record and it is falling faster then Cheney's approval rating. Not trying to get political (but it is true). Alright if you don’t know by now I really feel sorry for you. NEVER invest in the “cure for cancer” they will not find a cure they will find away to make you live with it. Don’t like that tuff break. The truth hurts. It is not like I want that don’t kill the informer. To be honest with you no company should be able to survive this. If it does I buy the CEOs a trophy for best killer that got away with it.

Recs

0
Member Avatar PueoFool (22.05) Submitted: 2/27/2008 12:33:39 PM : Outperform Start Price: $2.70 TELK Score: -95.14

This is my vegas-style gamble for the week.

Recs

0
Member Avatar invstm1000 (25.09) Submitted: 10/22/2007 7:48:52 PM : Underperform Start Price: $3.84 TELK Score: +89.01

lousy management, questionable drug, all in all these is easy money selling short.

Recs

0
Member Avatar n00bs (< 20) Submitted: 6/21/2007 9:51:16 PM : Outperform Start Price: $3.40 TELK Score: -88.83

grab some points

Recs

0
Member Avatar majakblue (< 20) Submitted: 6/6/2007 3:53:47 PM : Underperform Start Price: $3.52 TELK Score: +88.95

Gotta love those pharma wannabes. Phase III trials a bust, no profitability, spend the money on lottery tickets--less risk. Come on TELIK, improve my score ;->.

Recs

0
Member Avatar POWFred (37.91) Submitted: 5/3/2007 5:27:44 PM : Outperform Start Price: $6.00 TELK Score: -91.92

small pharma company with a few things in the pipeline. success and take over, or slow growth over longer time say 5 years.

Recs

0
Member Avatar 0l0l (< 20) Submitted: 4/18/2007 2:30:27 AM : Outperform Start Price: $6.40 TELK Score: -94.78

Telcyta works.

Recs

0
Member Avatar Moska (< 20) Submitted: 2/18/2007 8:32:47 PM : Outperform Start Price: $5.66 TELK Score: -95.52

Despite its failure in the drug tests, it has been way oversold and still has potential to bring in other drugs.

Recs

0
Member Avatar genedom (95.77) Submitted: 2/1/2007 2:56:17 AM : Underperform Start Price: $6.72 TELK Score: +96.96

No hope.

Recs

0
Member Avatar Comatosis2007 (< 20) Submitted: 12/28/2006 9:23:06 AM : Underperform Start Price: $4.40 TELK Score: +96.83

Nothing of value anymore.

Recs

0
Member Avatar vic50us (< 20) Submitted: 12/21/2006 10:10:35 PM : Outperform Start Price: $15.79 TELK Score: -100.19

huge investment must have results

Recs

0
Member Avatar ponyman1331 (30.66) Submitted: 12/16/2006 11:34:06 AM : Outperform Start Price: $16.90 TELK Score: -99.62

will show positive results in phase 3 test

Recs

0
Member Avatar mmachiz (79.07) Submitted: 12/14/2006 11:49:48 PM : Outperform Start Price: $16.44 TELK Score: -99.38

phase three results about to be announced will be favorable, delays in announcing results to date can only be explained by unusual survival benefits

Recs

0
Member Avatar target213 (< 20) Submitted: 10/10/2006 3:43:10 PM : Outperform Start Price: $17.62 TELK Score: -105.06

I think there will be news regarding their drug line

Recs

0
Member Avatar bighorse4 (< 20) Submitted: 10/9/2006 12:53:19 PM : Outperform Start Price: $17.67 TELK Score: -105.29

bio meds are way over sold. This bling bling is an FDA approval away from a real gem.

Recs

0
Member Avatar not2lazy (< 20) Submitted: 9/20/2006 4:47:54 AM : Outperform Start Price: $17.71 TELK Score: -107.51

Critical data due anytime

Recs

0
Member Avatar bioman100 (< 20) Submitted: 8/24/2006 10:07:41 PM : Outperform Start Price: $16.72 TELK Score: -110.17

breakthrough cancer drugs in development

Results 1 - 17 of 17

Featured Broker Partners


Advertisement